Matches in Nanopublications for { ?s ?p "[At higher doses, differences between the TP53-mutated lines were observed with TOV-112D being less sensitive to cisplatin than OV-90 that also harbors a CDNK2A mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP754635.RAd3Cf86P5z4ehaBP1oI0rxWpEFRobhdCCuAiwxe_-JgE130_assertion description "[At higher doses, differences between the TP53-mutated lines were observed with TOV-112D being less sensitive to cisplatin than OV-90 that also harbors a CDNK2A mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754635.RAd3Cf86P5z4ehaBP1oI0rxWpEFRobhdCCuAiwxe_-JgE130_provenance.
- assertion description "[At higher doses, differences between the TP53-mutated lines were observed with TOV-112D being less sensitive to cisplatin than OV-90 that also harbors a CDNK2A mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP452431.RAXOu-aSJiQbCsoErs2pAKCrbNkKPSWRkjDp9VK2DpG10130_assertion description "[At higher doses, differences between the TP53-mutated lines were observed with TOV-112D being less sensitive to cisplatin than OV-90 that also harbors a CDNK2A mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452431.RAXOu-aSJiQbCsoErs2pAKCrbNkKPSWRkjDp9VK2DpG10130_provenance.
- NP452433.RA6fDT9hTIUjuCmpcYetJ2Q0C4-ORNEFjnoS58WWbe4p4130_assertion description "[At higher doses, differences between the TP53-mutated lines were observed with TOV-112D being less sensitive to cisplatin than OV-90 that also harbors a CDNK2A mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452433.RA6fDT9hTIUjuCmpcYetJ2Q0C4-ORNEFjnoS58WWbe4p4130_provenance.